Keros Therapeutics Funding: $79M Raised, Series C (2020)
Keros Therapeutics is based in Lexington. It has raised $79M in total funding. Latest round: Series C.
Keros Therapeutics funding overview
Keros Therapeutics is based in Lexington. Keros Therapeutics has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2020. The round record for Keros Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Foresite Capital, OrbiMed, Cowen Healthcare Investments, Venrock, Pontifax, Arkin Bio Ventures and 3 others. 9 distinct backers are named across the disclosed rounds.
Keros Therapeutics at a glance
Total raised
$79M
Latest round
Series C
Latest round date
March 2020
Headquarters
Lexington
Notable investors
Foresite Capital, OrbiMed, Cowen Healthcare Investments, Venrock, Pontifax, Arkin Bio Ventures, Partners Innovation Fund, Global Health Sciences Fund
Frequently asked about Keros Therapeutics funding
How much has Keros Therapeutics raised?
Keros Therapeutics has raised $79M in total disclosed funding across the rounds on record.
Who has invested in Keros Therapeutics?
Foresite Capital, OrbiMed, Cowen Healthcare Investments, Venrock, Pontifax, Arkin Bio Ventures are named among the investors backing Keros Therapeutics.
What was the latest Keros Therapeutics funding round?
The most recent disclosed round is a Series C, announced in March 2020.
Where is Keros Therapeutics based?
Keros Therapeutics is based in Lexington.
When did Keros Therapeutics last raise?
The last disclosed Keros Therapeutics round closed in March 2020 at Series C.
Keros Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Lexington below to benchmark round size and investor mix.
